FKnol.com

Financial Knowledge & Information Portal

Perrigo (PRGO) Company Profile

Updated Jun 2, 2020
Perrigo has the following business profile:
Company's Full Name:Perrigo
Short Name:Perrigo
Trading Ticker Symbol:PRGO
Primary Exchange:NYSE
Headquarter City/Country:Dublin, Ireland
Primary Industry Sector:Health Care
Seconday Sub-sector:Major Pharmaceuticals
Main Business Areas: Health Care, Major Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Pharma, Healthcare, S&P 500
Dividend Payments:Dividend History
ETFs Holding:List of ETFs holding Perrigo stock

Market and Trading Information for Perrigo

The following details were available for trading and market data about the stock of Perrigo as of writing:
Current Share Price:$56.38
Previous Year's Closing Price:$51.66
Percentage Price Change (YTD):9.14%
Market Cap:$7.69 billion
52-week Price Range:$40.01 - $63.86
Dividend Per Share:$0.82
EPS (TTM):1.37
Price-Earnings (Trailing):41.06
Price-Earnings (Forward):12.9

Company Profile and Business Description for Perrigo

Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences and Other. The Company manufactures OTC healthcare products and supplies infant formulas for the store brand market. It is also a provider of generic extended topical prescription products. It provides healthcare products across a range of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.

Consumer Healthcare

The Company's CHC segment is focused on the sale of OTC store brand products, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health and diagnostic products. The Company markets in various geographies, including the United States, the United Kingdom and Mexico. Its branded products include the Good Sense, Sergeant's, Sentry, Herron, PetArmor value brands, and the ScarAway brand name.

Branded Consumer Healthcare

The Company's BCH segment develops, manufactures, markets and distributes various European OTC brands in categories, such as natural health, cough, cold and allergy, personal care and derma-therapeutics, lifestyle and pain relief. In addition, the segment manages its regulatory, sales and distribution infrastructure to in-license, and sells non-owned brands and generic pharmaceutical products.

Prescription Pharmaceuticals

The Company's Rx segment develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs for the United States and the United Kingdom markets. It offers a range of topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions and powders. The portfolio also includes select controlled substances, injectables, hormones, women's health products, oral solid dosage forms and oral liquid formulations. Its development areas include other delivery systems, such as oral liquids, metered dose inhalers, injectables and transdermal products. In addition, the Rx segment offers OTC products through the prescription channel (referred to as ORx, these products are marketed using the Perrigo name). ORx products are OTC products that are available for pharmacy fulfillment and healthcare reimbursement when prescribed by a physician. It offers various ORx products that are reimbursable through various health plans and the United States Medicaid and Medicare programs. It manufactures and distributes a range of generic prescription products under various brand names, including Differin, BenzaClin, Entocort, Evoclin, Duac, Olux, Olux-E, Clobex, Desonate, Tridesilon, D.H.E. 45, Ultravate, Bactroban, Mycostatin, Elimite, Klor-Con, Protopic, Androgel, Depo, Testosterone and Triderm/Kenalog.

Specialty Sciences

The Company's Specialty Sciences segment consists of assets focused on the treatment of multiple sclerosis, specifically in connection with the drug, Tysabri (natalizumab). Tysabri also focused on the treatment of Crohn?«÷s diseases.

Other

The Company's Other segment consists of active pharmaceutical ingredients (API) business. It develops, manufactures and markets API products, which are used across the world by both generic and branded pharmaceutical companies. Certain of these ingredients are used in its own pharmaceutical products. The manufacturing of API occurs in Israel with some production in India.

The Company competes with LNK International, Inc., PL Developments, International Vitamin Corporation, Dr. Reddy's Labs, Johnson & Johnson, Pfizer, Bayer AG, Nestle S.A., Abbott Nutrition, NBTY, Mead Johnson Nutrition Co., Reckitt Benckiser, Boehringer Ingelheim, Novartis, Allergan plc, Apotex Corp., Glenmark Generics Inc., Impax Laboratories, Inc., Mylan N.V., Prasco, LLC, Sandoz, Sun Pharmaceuticals, Taro Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Triax Pharmaceuticals, LLC and Zydus Pharmaceuticals, Inc.

Treasury Building

ETFs Holding Perrigo Stock

As of March 2020, the following exchange-traded funds (ETF) hold the Perrigo stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Perrigo stock holding. There are a total of 124 ETFs in Fknol.com records which are holding Perrigo stock in their portfolio. See Full List.

TickerNameShort DescriptionExpense
Ratio
No. of
Holdings
Dividend
Frequency
ACWIiShares MSCI ACWI ETFThe iShares MSCI ACWI ETF tracks a market-cap-weighted index of large- and midcap global stocks, covering 85% of the developed and emerging markets capitalization. ...Full Details ...Candlestick Patterns.0.32%1596
Full List
Semi-Annually
CSMProshares Large Cap Core PlusThe ProShares Large Cap Core Plus ETF tracks a long/short index of the 500 largest US stocks. It uses a set of rules to assign weights to each equity that add up to 130% long and 30% short exposure. ...Full Details0.45%320
Full List
Quarterly
DGROiShares Core Dividend Growth ETFThe iShares Core Dividend Growth ETF tracks an index of US stocks that are selected by dividends, dividend growth and payout ratio, then weighted by dividend dollars. ...Full Details0.08%449
Full List
Quarterly
ESGSColumbia Sustainable US Equity Income ETFThe Columbia Sustainable U.S. Equity Income ETF tracks an index composed of 100 U.S. equities (excluding REITs) that exhibit a minimum ESG rating (as determined by MSCI) and dividend characteristics. ...Full Details0.35%101
Full List
Quarterly
ESGVVanguard ESG US Stock ETFThe Vanguard ESG U.S. Stock ETF tracks a market-cap-weighted index of US companies screened for environmental, social, and corporate governance (ESG) criteria. ...Full Details0.12%988
Full List
Quarterly
ESGWColumbia Sustainable Global Equity Income ETFThe Columbia Sustainable Global Equity Income ETF tracks an index composed of 200 companies from developed countries (excluding REITs) that exhibit a minimum ESG rating (as determined by MSCI) and dividend characteristics. ...Full Details0.4%201
Full List
Quarterly
FHLCFidelity MSCI Health Care Index ETFThe Fidelity MSCI Health Care ETF tracks a market-cap-weighted index of stocks in the broad US health care sector. ...Full Details0.08%345
Full List
Quarterly
FNDBSchwab Fundamental US Broad Market Index ETFThe Schwab Fundamental U.S. Broad Market Index ETF tracks a fundamentally selected and weighted Russell Index based on sales, cash flow and dividends/buybacks. ...Full Details0.25%1481
Full List
Quarterly
FNDXSchwab Fundamental US Large Company Index ETFThe Schwab Fundamental US Large Company Index ETF tracks a fundamentally selected and weighted Russell index based on sales, cash flow and dividends/buybacks. ...Full Details0.25%671
Full List
Quarterly
IECSiShares Evolved US Consumer Staples ETFThe iShares Evolved U.S. Consumer Staples ETF is an actively managed, market-cap-weighted fund of large-, mid-, and small-cap US stocks in the consumer staples sector, according to an alternative classification system defined by machine learning algorithms. ...Full Details0.18%128
Full List
Annually

See Full List of ETFs holding Perrigo stock in their respective portfolios.

Peer / Competitor Companies of Major Pharmaceuticals Sector

Along with Perrigo, the following other peer (competitor) companies also exist within the same Major Pharmaceuticals - Health Care sector whose company profile and dividend history is as follows:

▶ Abbott Labs (ABT): Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical ....See Detailed Company Profile,  Dividend History  and Recent Candlestick Patterns.

▶ AbbVie (ABBV): AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ....See Detailed Company Profile,  Dividend History  and Recent Candlestick Patterns.

▶ Abeona Therapeutics (ABEO): Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ....See Detailed Company Profile,  Dividend History

▶ AC Immune SA (ACIU): AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ....See Detailed Company Profile,  Dividend History

▶ ACADIA Pharma (ACAD): ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ....See Detailed Company Profile,  Dividend History

▶ Acasti Pharma (ACST): Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ....See Detailed Company Profile,  Dividend History

▶ AcelRx Pharma (ACRX): AcelRx Pharmaceuticals, Inc., incorporated on July 13, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company ....See Detailed Company Profile,  Dividend History

▶ Achillion Pharma (ACHN): Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and ....See Detailed Company Profile,  Dividend History

▶ Aclaris Therapeutics (ACRS): Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ....See Detailed Company Profile,  Dividend History

▶ Actinium Pharma (ATNM): Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ....See Detailed Company Profile,  Dividend History

▶ Acura Pharma (ACUR): Acura Pharmaceuticals, Inc., incorporated on April 10, 1935, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication ....See Detailed Company Profile,  Dividend History

▶ Adamas Pharma (ADMS): Adamas Pharmaceuticals, Inc., incorporated on November 15, 2000, is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic ....See Detailed Company Profile,  Dividend History

▶ Adamis Pharma (ADMP): Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products ....See Detailed Company Profile,  Dividend History

▶ Aduro Biotech (ADRO): Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ....See Detailed Company Profile,  Dividend History

▶ Advaxis (ADXS): Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ....See Detailed Company Profile,  Dividend History

▶ Aeglea BioTherapeutics (AGLE): Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ....See Detailed Company Profile,  Dividend History

▶ AEterna Zentaris (AEZS): Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and womens health. The Company operates through the ....See Detailed Company Profile,  Dividend History

▶ Affimed (AFMD): Affimed N.V., incorporated on May 1, 2014, is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Companys product candidates are developed in the field of immuno-oncology, ....See Detailed Company Profile,  Dividend History

▶ Agile Therapeutics (AGRX): Agile Therapeutics, Inc., incorporated on December 5, 1997, is a womens health specialty pharmaceutical company. The Company is focused on the development and commercialization of prescription contraceptive products. Its product ....See Detailed Company Profile,  Dividend History

▶ Agios Pharma (AGIO): Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ....See Detailed Company Profile,  Dividend History

... See Full List of All Stocks of Major Pharmaceuticals Sector.

Stock List of Other Health Care Sub-sectors

▶ Stocks of Biotech Sector

▶ Stocks of Biotech Apparatus Sector

▶ Stocks of Biotech Diagnostics Sector

▶ Stocks of Biotech Products Sector

▶ Stocks of Biotech Research Sector

▶ Stocks of Biotechnology Sector

▶ Stocks of Diagnostics & Research Sector

▶ Stocks of Drug Delivery Sector

▶ Stocks of Drug Development Sector

▶ Stocks of Drug Manufacturer Sector

▶ Stocks of Drug ManufacturersóSpecialty & Generic Sector

▶ Stocks of Health Care Sector

▶ Stocks of Health Care Equipment and Services Sector

▶ Stocks of Hospital and Nursing Management Sector

▶ Stocks of Industrial Specialties Sector

▶ Stocks of Major Pharmaceuticals Sector

▶ Stocks of Medical Care Facilities Sector

▶ Stocks of Medical Dental Instruments Sector

▶ Stocks of Medical Devices Sector

▶ Stocks of Medical Electronics Sector

▶ Stocks of Medical Instruments & Supplies Sector

▶ Stocks of Medical Nursing Services Sector

▶ Stocks of Medical Products Sector

▶ Stocks of Medical Specialities Sector

▶ Stocks of Ophthalmic Goods Sector

▶ Stocks of Other Pharmaceuticals Sector

▶ Stocks of Precision Instruments Sector


Stock List of Other Top-level Sectors

▶ Stocks of Sector

▶ Stocks of Basic Industries Sector

▶ Stocks of Basic Materials Sector

▶ Stocks of Capital Goods Sector

▶ Stocks of Communication Services Sector

▶ Stocks of Consumer Cyclical Sector

▶ Stocks of Consumer Defensive Sector

▶ Stocks of Consumer Discretionary Sector

▶ Stocks of Consumer Durables Sector

▶ Stocks of Consumer Non-Durables Sector

▶ Stocks of Consumer Services Sector

▶ Stocks of Energy Sector

▶ Stocks of Finance Sector

▶ Stocks of Financial Services Sector

▶ Stocks of Health Care Sector

▶ Stocks of Healthcare Sector

▶ Stocks of Industrials Sector

▶ Stocks of Miscellaneous Sector

▶ Stocks of Public Utilities Sector

▶ Stocks of Real Estate Sector

▶ Stocks of Services Sector

▶ Stocks of Technology Sector

▶ Stocks of Transportation Sector

▶ Stocks of Utilities Sector